| Literature DB >> 35295223 |
Manon Auguste1, Daniela Melillo2, Annunziata Corteggio2, Rita Marino3, Laura Canesi1, Annalisa Pinsino4, Paola Italiani2,3, Diana Boraschi2,3,5.
Abstract
Assessing the impact of drugs and contaminants on immune responses requires methodological approaches able to represent real-life conditions and predict long-term effects. Innate immunity/inflammation is the evolutionarily most widespread and conserved defensive mechanism in living organisms, and therefore we will focus here on immunotoxicological methods that specifically target such processes. By exploiting the conserved mechanisms of innate immunity, we have examined the most representative immunotoxicity methodological approaches across living species, to identify common features and human proxy models/assays. Three marine invertebrate organisms are examined in comparison with humans, i.e., bivalve molluscs, tunicates and sea urchins. In vivo and in vitro approaches are compared, highlighting common mechanisms and species-specific endpoints, to be applied in predictive human and environmental immunotoxicity assessment. Emphasis is given to the 3R principle of Replacement, Refinement and Reduction of Animals in Research and to the application of the ARRIVE guidelines on reporting animal research, in order to strengthen the quality and usability of immunotoxicology research data.Entities:
Keywords: humans; in vitro; in vivo; innate immunity; innate memory; invertebrates
Year: 2022 PMID: 35295223 PMCID: PMC8915809 DOI: 10.3389/ftox.2022.842469
Source DB: PubMed Journal: Front Toxicol ISSN: 2673-3080
SWOT analysis of animal species for immunotoxicological assessment.
| Species | Strengths | Weaknesses | Opportunities | Threats |
|---|---|---|---|---|
| Mussel | • Knowledge on anatomy and physiology | • No long-term cell cultures/cell lines | • Non-invasive sampling immune cells | • Seasonal variability (due to environmental factors, |
| • Cosmopolitan, allow comparison | • Bias on cell subtypes (granulocytes more represented), except in cytofluorimetry | • No ethical problems | ||
| • Simple, easy to handle | • Inter-individual variability (high intraspecific genome and environment-related diversity) | • Aquaculture species, not endangered | ||
| • Suitable for | • Resilient to biotic and abiotic stressors | |||
| Tunicates | • Cosmopolitan invasive species | • No long-term cell cultures/cell lines | • Non-invasive haemolymph withdrawal | • Poor molecular characterization of haemocytes/immune cells |
| • Simple, easy to handle | • Many haemocyte types with different activities | • No ethical problems | • Seasonal variability | |
| • Suitable for | • Inter-individual variability if coming from different environments | • Non-edible species | ||
| • Colonial species suitable for allorecognition studies | ||||
| Sea urchin | • Low maintenance and handling costs | • Maintenance in aquaria without stress is challenging | • Medium-term primary cell culture | • Rare in some coastal environments |
| • Knowledge on anatomy and physiology | • Very high number of immune receptor-encoding genes | • No ethical issues | • Seasonal variability | |
| • Versatility (enough to satisfy | • Stable cell lines unavailable | • Resilience and adaptation | ||
| • Unknown variability between different environments | • Longevity and lack of neoplastic diseases | |||
| • Close genetic relationship with humans | ||||
| Human ( | • Validated workflows and methodologies | • Mainly | • Non-invasive sampling of immune cells | • Inter- and intra-laboratory reproducibility of methods and reagents |
| • Possibility to reproducing | • Ethical approval required | • Development of high-throughput methodologies | • Inter-donor variability ( | |
| • Availability of long-term cell culture (including cell lines) | • Development of a Human Screening Platform | |||
| • Availability of many well characterized reagents ( | • Higher predictivity of human cell-based models vs. other animal models |
SWOT analysis of in vivo animal models for immunotoxicity assessment.
| Species | Strengths | Weaknesses | Opportunities | Threats |
|---|---|---|---|---|
| Mussel | • Large source of cells | • High number of animals needed | • Different routes of exposure (water, dietary, injection) | • Seasonal changes |
| • Consider the animal in its whole (circulating fluid and different tissues) | • Long experimental preparations | • Control all external factors | • Dietary exposure (natural) needs accurate quantitative assessment | |
| • Suitable for studying longer term effects | ||||
| • Possibility to study immune cell metabolism | ||||
| Tunicates | • Whole organism/cell population evaluation | • Lack of immune “healthy state” benchmarks | • Use of housed animals or reared-in-house animals to control environmental conditions | • High variability among individuals |
| • Identification of tissue-specific responses | • Exposure time is critical | • Examining the role of immunosenescence | • Influence of non-immune parameters on immune functions (age, nutrition, etc.) | |
| • Possibility to study immune cell metabolism | • Specific functions ( | • Seasonal variability | ||
| Sea urchin | • High number of circulating cells | • High number of specimens required | • Possibility of controlling the immunological state (quiescence | • Gender differences in immune response |
| • Long and repeated experimental exposure possible | • High requirement of space/number of tanks for exposure experiments | • Possibility of a comprehensive understanding of immunity (immune cells, microbiota) | • High baseline immune activity in freshly caught animals (acclimation period necessary) | |
| • Immune functions not affected by age | • Seasonal variability | |||
| • Possibility to study immune cell metabolism |
SWOT analysis of in vitro experimental methods in different animal models for immunotoxicity assessment.
| Species | Method/parameter | Strengths | Weaknesses | Opportunities | Threats |
|---|---|---|---|---|---|
| Mussel | Analysis of haemolymph and haemocytes | • Study of hemocyte monolayers alone or in whole hemolymph | • Short term cell survival once extracted from the animal (up to 24 h) | • Low number of animals needed | • No cell line available or long-term cultures for routine check |
| • Large hemolymph quantity (ml) | • Toxicokinetic studies required for correctly assessing exposure and uptake | • Haemocytes can be kept under non strictly sterile conditions | |||
| • Can be maintained in easy, cheap medium | |||||
| Tunicates | Analysis of haemolymph parameters | •Identification of immunologically active molecules | • Dose- and exposure time-dependent response | • Correlation between humoral factors and haemocyte population composition | • High variability among individuals |
| • Toxicokinetic studies required for correctly assessing exposure and uptake | |||||
| RNA expression | • Suitable for tissues and isolated cells | • Lack of immune “healthy state” benchmarks | • Providing a wide immune gene expression profiling in healthy and frail conditions ( | • High variability among individuals | |
| • Need of functional counterpart | |||||
| Haemocytes in suspension | • Automated reading | • Lack of cell-specific markers | • Evaluation of haematopoiesis rate | • Does not reflect the immune functions/changes at the level of the entire organism | |
| • Functional evaluation | |||||
| • Evaluation of whole haemocyte population | |||||
| Haemocyte short-term cultures (on plate/slide) | • Easy to manage | • Largely limited to microscopical evaluation (light and fluorescence microscopy) | • Development of assays | • Inter-operator variability | |
| • Inexpensive | • Few soluble molecules characterized | ||||
| • Fast | • Lack of cell-specific markers | ||||
| • Functional assays possible | |||||
| • RNA expression and protein production possible | |||||
| Sea Urchin | Primary cell culture | • Simple optimised protocol | • Limited immune cell proliferation | • Development of assays | • Need of validation of assay predictivity |
| • Easy and cheap medium (blood fluid, anticoagulant solution, artificial seawater) | • Limited duration in culture (2 weeks) | ||||
| • Low number of donors necessary | • Skill required in blood withdrawal | ||||
| • High number of cells per donor | • Specific cell density conditions necessary | ||||
| • Mixed cell population or single cell type culture | • Toxicokinetic studies required for correctly assessing exposure and uptake | ||||
| Human | Conventional 2D cultures of established monocyte-like cell lines (THP-1, U937) | • Relatively low cost | • Cells are not normal and may not retain the original characteristics and functions | • Possibility of developing excellent, fast and reproducible assays based on valid representative cell functions | • Inter- and intra-laboratory genotypic variations may generate irreproducible and conflicting results |
| • Unlimited source of cells | • Use of mouse cell lines for human toxicity testing adds representativity problems | • Risk of examining effects that never occur in real life | |||
| • Limited variations in cell responses | • No microenvironmental and intercellular mechanical and chemical cross-talk | ||||
| • Standardised culture conditions | • Toxicokinetic studies required for correctly assessing exposure and uptake | ||||
| Conventional 2D cultures of primary immune cells derived from donors | • High physiological relevance | • Relatively high cost | • Possibility to detect disease-caused changes in primary immune cell functional phenotypes | • Need of kinetic analysis for examining medium/long-term effects, in most cases impossible because of the short cellular lifespan | |
| • Possibility to develop tissue-like mature cells ( | • Donor-to donor variation (genetic heterogeneity and immunobiography) | ||||
| • More complex culture conditions | |||||
| • Need of technical skills | |||||
| • Low number of cells for functional experiments | |||||
| • Limited microenvironment and intercellular communication | |||||
| • Only short-term cultures possible without substantial alterations of cell functions ( | |||||
| • Toxicokinetic studies required for correctly assessing exposure and uptake | |||||
| 3D co-culture systems | • More accurate representation of | • Complex culture conditions | • Possibility to evaluate global effects on different cell types | • It cannot reproduce the complexity of architectural microenvironment | |
| • Reproduction of intercellular communication | • Difficulties for long-term culture of primary cell | • Problem of compatibility between the different cell types and unwanted immune activation | |||
| • Increased relevant cell-to-cell and cell-to-ECM signalling | • Variability of biological matrices may lead to irreproducible results | ||||
| • Toxicokinetic studies required for correctly assessing exposure and uptake | |||||
| Organs-on-chip | • High physiological relevance | • High cost | • Possibility to develop a testing platform for toxicological safety assessment | • Challenging model validation | |
| • Reproduction of tissue/organ level organization | • Need of specific expertise | • Possibility to integrate cell technology, microenvironment and personalised parameters for the development of precision medicine | • Problem of compatibility between the different cell types and unwanted immune activation | ||
| • Patient-derived models | • Oversimplified organ model | ||||
| • Reproduction of intercellular communication | • Difficult to standardise | ||||
| • Realistically monitoring of human immune cell reactivities | • Toxicokinetic studies required for correctly assessing exposure and uptake |
FIGURE 1Schematic representation of experimental immune assessments using the mussel Mytilus galloprovincialis. Studies can be performed at the whole animal level with in vivo experiments or on isolated haemocytes and haemolymph with in vitro assays.
FIGURE 2Immune responses and defensive reactions in Ciona robusta. Following exposure to inflammatory molecules (LPS), immunocompetent haemocytes are activated, and granular haemocytes release antimicrobial peptides, the cytokines TNFα and IL-17, phenoloxidase and complement components. These molecules participate to cellular defence activities, such as phagocytosis, encapsulation and wound healing, and recruit other immune cells to the sites of inflammation. Exposure to toxicants activates a detoxifying system (thiol-containing molecules) through the direct release of metallothioneins, GSH and phytochelatins by granular haemocytes. Exposure to inflammatory/toxic agents modulates the expression of immune-related genes and activates haematopoiesis.
FIGURE 3Immune defensive reactivity of sea urchin to external stimuli and toxicants. Schematic depiction of the immune functions, molecules, and signalling pathways activated during the sea urchin defensive response to threats and toxicants. Upper left: sea urchin anatomy. SRCR: Scavenger Receptor Cysteine-Rich; TLR: Toll-like receptor; NLR NOD-like receptor.
FIGURE 4Immunotoxicity evaluation in human cells. The most used in vitro models/systems are based on cell lines or primary cells (e.g., leukocytes isolated from whole blood). They encompass conventional 2D cultures, 3D co-cultures and the more innovative Organs-on-ChiP arrays. The whole blood can be considered as a “ready-to-use” system. 2D cultures with monocytic cell lines (e.g., THP-1 or U937) or with the more reliable primary cells (e.g., monocytes, NK or DC) are mainly used to measure the inflammatory reactivity of innate immune cells. Conversely, the Whole Blood Assay (WBA; based on the use of anticoagulated whole blood) allows us to study the global reactivity of blood cells. Overall, the immunotoxicity is evaluated by measuring several biological and functional endpoints through different evaluation techniques. The main techniques and endpoints are shown.
SWOT analysis of the cross-species assays/endpoints for immunotoxicity assessment.
| Endpoint | Assay | Strengths | Weaknesses | Opportunities | Threats | |
|---|---|---|---|---|---|---|
| Cytotoxicity assays | ||||||
| Cell viability | Trypan blue | • Fast, cheap | • Dye not stable over time | • Application to a large panel of species | • The dye is toxic | |
| • Reproducible | • Require fresh haemocytes | |||||
| • Few materials required | • Viability may be overestimated (apoptotic cells appear viable) | |||||
| MTT | • Robust | • Used on adherent cells | • Protocols adaptable to a large panel of species | • No clear relationship between metabolic activity and cell number | ||
| • Easy to use | • Cell detachment during supernatant removal | |||||
| • High sensitivity | • Chemical interference | |||||
| • Gold standard for cytotoxicity testing | • It only measures metabolically active cells | |||||
| • Kits are expensive | ||||||
| Lysosomal Membrane Stability (LMS) | • Vital staining | • Applies only to granulocytes | • Use in standardised protocols and guidelines | • Limited to adherent cells | ||
| • Single cell information | • Additional information on cell shape | • Requires training for appropriate identification of parameters | ||||
| LDH release | • Robust | • Serum has LDH activity | • Provides information on cell membrane integrity and irreversible cell death | • It does not include other cytotoxic features ( | ||
| • Reliable | • Kits are expensive | • Mostly used in human cells but applicable to invertebrates | ||||
| • Simple evaluation | ||||||
| Apoptosis | Detection of apoptosis-related changes ( | • Provides early signs of apoptosis | • Low solubility in seawater for some probes | • Common probes for different species | • Can be toxic for cells | |
| • Single cell information | • Some interactions of the probes with other cell membrane components can create artefacts | • Can add mechanistic information on the toxicity data | • High cost | |||
| • Photo-bleaching | • Sensitive to changes in the exposure medium ( | |||||
| Genotoxicity DNA damage | Comet assay | • Sensitivity for detecting low levels of damage | • Only applicable to fresh cells | • Applicable to many species | • Genotoxic damage is not to be taken as health risk, as it refers to some cells rather than to the entire organism (unless when affecting some specific cell types) | |
| • Requires small number of cells per sample | • Long sample preparation process | |||||
| • Does not distinguish between different types of damage (single/double strand breaks, apoptotic fragments, | ||||||
| • Does not identify mutations | ||||||
| Evaluation of cell number and phagocytic capacity | ||||||
| Total and subpopulation cell counts | Microscopy, Flow Cytometry | • Provides a general picture of the whole population | • Requires specialised expertise | • Allows to compare samples between different conditions (activation phases, health status, season, etc.) | • Method standardization can vary among labs | |
| • Provides number and frequency of subpopulations | • Requires special instrumentation (cytofluorimeter) | • Changes may be due to or masked by external factors | ||||
| • Accurate single cell phenotypic characterization with analysis of multiple markers | • Affected by seasonality (in marine invertebrates) | |||||
| Phagocytosis | Fluorescent bacteria or zymosan particles | • Simple recognition and cell counting (fluorescent microscopy) | • Apply mainly to granulocytes/adherent cells (microscopy) | • Applicable to many species | • Bell-shaped dose response curve | |
| • Fast (cytofluorimetry) | • Time consuming (microscopy) | • Allows to identify cell subpopulations | • No info on phagocytosis rate unless the entire cell population is sampled | |||
| • Small sample volume required | • Requires special instruments (cytofluorimeter, fluorescence microscope) and skilled personnel | |||||
| Production of defensive and immune-related molecules | ||||||
| Lysozyme release | Hydrolysis of | • Can be evaluated in serum | • Kinetic measurements that require temperature control | • Applicable to many species | • Affected by seasonality in invertebrates | |
| • Low cost | ||||||
| Reactive oxygen species (ROS) | Cytochrome C reduction | • Efficient in evaluating extracellular ROS release | • Cyt C can interact with other enzymes | • Applicable to many species | • Affected by seasonality (for marine organisms) | |
| • Fast | • High cost | • Low detection for ROS generated in organelles | ||||
| Use of fluorescent probes ( | • Intracellular detection | • Cell auto-florescence can interfere with the ROS-generated signal | • Suitable for respiratory burst | • Does not distinguish between different ROS | ||
| • Cell permeable probes | ||||||
| NO production | Griess reaction | • Provide a quantifiable reaction | • High limit of detection (µM range) | • Can be further modified or completed to detect other nitrogen species | • Susceptible to contamination | |
| • Low cost | • Limited to nitrite detection | • Reagent can interfere with serum components | ||||
| Use of fluorescent probes ( | • Provide details/localization in cell | • Low cell membrane permeability | • Can be used for different species | • Can react with other NO metabolites | ||
| • Low detection limit (nM range) | ||||||
| Immune-related gene and marker expression | ||||||
| Immune gene expression | Transcription by qRT-PCR | •Quantitative gene expression levels | • Information limited to the examined genes, no protein/functional information | • Informative implementation of functional data | • Limited primer availability for some organisms | |
| • Normalization required for quantitative measurements | ||||||
| Unbiased immune marker detection | Transcriptomics, proteomics, lipidomics, metabolomics | • Analysis of changes in activation pathways and protein repertoires | • Excess of data that may be difficult to handle properly | • Can offer a large coverage of the putative mechanisms involved in immunotoxicity | • Should be combined with functional assays | |
| • Applicable at the single cell level for assessing population functional heterogeneity | • Expensive | • Highly informative for organisms for which other methods are unavailable ( | ||||
| • Specialised skills and instrumentation required | ||||||